Discontinuation report ANACIN
Report ID | 189549 |
Drug Identification Number | 02332450 |
Brand name | ANACIN |
Common or Proper name | Anacin |
Company Name | PALADIN PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | CAFFEINE ACETYLSALICYLIC ACID |
Strength(s) | 32MG 325MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 200 tablets |
ATC code | N02BA |
ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2023-04-15 |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-04-13 | French | Compare |
v1 | 2023-04-13 | English | Compare |
Showing 1 to 2 of 2